Clinical Trial Update: Direct Antiviral Agents for Hepatitis C Virus-associated Cryoglobulinaemia Vasculitis

View source ↗

Summary

This clinical trial update discusses the use of direct-acting antivirals to treat hepatitis C virus–associated cryoglobulinemic vasculitis; the current trial st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryoglobulinemia
• Cryoglobulinemic Vasculitis
• Hepatitis C

Drugs mentioned

• Direct-acting antivirals (DAAs)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Vasculitis, Cryoglobulinemia | Status: UNKNOWN